Direct lineage reprogramming of mouse fibroblasts to functional midbrain dopaminergic neuronal progenitors

Stem Cell Research

Volumn 12, Issue 1, 2014, Pages 60-68

  Kim, Han Seop ^a   Kim, Janghwan ^a,b   Jo, Yeonju ^a   Jeon, Daejong ^c   Cho, Yee Sook ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FIBROBLAST GROWTH FACTOR 8; GLYCOGEN SYNTHASE KINASE 3BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; JANUS KINASE; LMX1A PROTEIN; MORPHOGEN; NEUROGENIN 2; PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CELL FATE; CELL LINEAGE; CELL MEMBRANE DEPOLARIZATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PATCH CLAMP; PRIORITY JOURNAL; TRANSIENT EXPRESSION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; DOPAMINE; DOPAMINERGIC NEURONS; FIBROBLAST GROWTH FACTOR 8; FIBROBLASTS; GLYCOGEN SYNTHASE KINASE 3; HEDGEHOG PROTEINS; INDUCED PLURIPOTENT STEM CELLS; JANUS KINASES; MESENCEPHALON; MICE; NUCLEAR REPROGRAMMING; PYRIDINES; PYRIMIDINES; TRANSCRIPTION FACTORS;

EID: 84885972969     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.09.007     Document Type: Article

References (43)

1. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
2. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
3. Sancho-Martinez I., Baek S.H., Izpisua Belmonte J.C. Lineage conversion methodologies meet the reprogramming toolbox. Nat. Cell Biol. 2012, 14:892-899.
4. Liu G.H., Yi F., Suzuki K., Qu J., Izpisua Belmonte J.C. Induced neural stem cells: a new tool for studying neural development and neurological disorders. Cell Res. 2012, 22:1087-1091.
5. Matsui T., Takano M., Yoshida K., Ono S., Fujisaki C., Matsuzaki Y., Toyama Y., Nakamura M., Okano H., Akamatsu W. Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency. Stem Cells 2012, 30:1109-1119.
6. Kim J., Ambasudhan R., Ding S. Direct lineage reprogramming to neural cells. Curr. Opin. Neurobiol. 2012, 22:778-784.
7. Efe J.A., Hilcove S., Kim J., Zhou H., Ouyang K., Wang G., Chen J., Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 2011, 13:215-222.
8. Kim J., Efe J.A., Zhu S., Talantova M., Yuan X., Wang S., Lipton S.A., Zhang K., Ding S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7838-7843.
9. Gaillard A., Jaber M. Rewiring the brain with cell transplantation in Parkinson's disease. Trends Neurosci. 2011, 34:124-133.
10. Ganat Y.M., Calder E.L., Kriks S., Nelander J., Tu E.Y., Jia F., Battista D., Harrison N., Parmar M., Tomishima M.J., Rutishauser U., Studer L. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J. Clin. Investig. 2012, 122:2928-2939.
11. Pfisterer U., Kirkeby A., Torper O., Wood J., Nelander J., Dufour A., Bjorklund A., Lindvall O., Jakobsson J., Parmar M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10343-10348.
12. Caiazzo M., Dell'Anno M.T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T.D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R.R., Gustincich S., Dityatev A., Broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476:224-227.
13. Liu X., Li F., Stubblefield E.A., Blanchard B., Richards T.L., Larson G.A., He Y., Huang Q., Tan A.C., Zhang D., Benke T.A., Sladek J.R., Zahniser N.R., Li C.Y. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012, 22:321-332.
14. Kim J., Su S.C., Wang H., Cheng A.W., Cassady J.P., Lodato M.A., Lengner C.J., Chung C.Y., Dawlaty M.M., Tsai L.H., Jaenisch R. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 2011, 9:413-419.
15. Rhee Y.H., Ko J.Y., Chang M.Y., Yi S.H., Kim D., Kim C.H., Shim J.W., Jo A.Y., Kim B.W., Lee H., Lee S.H., Suh W., Park C.H., Koh H.C., Lee Y.S., Lanza R., Kim K.S. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J. Clin. Investig. 2011, 121:2326-2335.
16. Wang L., Huang W., Su H., Xue Y., Su Z., Liao B., Wang H., Bao X., Qin D., He J., Wu W., So K.F., Pan G., Pei D. Generation of integration-free neural progenitor cells from cells in human urine. Nat. Methods 2012, 10:84-89.
17. Thier M., Worsdorfer P., Lakes Y.B., Gorris R., Herms S., Opitz T., Seiferling D., Quandel T., Hoffmann P., Nothen M.M., Brustle O., Edenhofer F. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell stem cell 2012, 10:473-479.
18. Han D.W., Tapia N., Hermann A., Hemmer K., Hoing S., Arauzo-Bravo M.J., Zaehres H., Wu G., Frank S., Moritz S., Greber B., Yang J.H., Lee H.T., Schwamborn J.C., Storch A., Scholer H.R. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 2012, 10:465-472.
19. Lu J., Liu H., Huang C.T., Chen H., Du Z., Liu Y., Sherafat M.A., Zhang S.C. Generation of integration-free and region-specific neural progenitors from primate fibroblasts. Cell Rep. 2013, 3:1580-1591.
20. Cho M.S., Hwang D.Y., Kim D.W. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat. Protoc. 2008, 3:1888-1894.
21. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23:781-790.
22. Roussa E., Krieglstein K. Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-beta. Cell Tissue Res. 2004, 318:23-33.
23. Momcilovic O., Montoya-Sack J., Zeng X. Dopaminergic differentiation using pluripotent stem cells. J. Cell. Biochem. 2012, 113:3610-3619.
24. Swistowski A., Peng J., Liu Q., Mali P., Rao M.S., Cheng L., Zeng X. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010, 28:1893-1904.
25. Aguila J.C., Hedlund E., Sanchez-Pernaute R. Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy. Stem Cells Int. 2012, 2012:412040.
26. Roybon L., Hjalt T., Christophersen N.S., Li J.Y., Brundin P. Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28:3644-3656.
27. Studer L. Derivation of dopaminergic neurons from pluripotent stem cells. Prog. Brain Res. 2012, 200:243-263.
28. Efe J.A., Ding S. The evolving biology of small molecules: controlling cell fate and identity. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2011, 366:2208-2221.
29. Efe J.A., Ding S. Reprogramming, transdifferentiation and the shifting landscape of cellular identity. Cell cycle 2011, 10:1886-1887.
30. van Oosten A.L., Costa Y., Smith A., Silva J.C. JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat. Commun. 2012, 3:817.
31. Yang J., van Oosten A.L., Theunissen T.W., Guo G., Silva J.C., Smith A. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 2010, 7:319-328.
32. Prakash N., Brodski C., Naserke T., Puelles E., Gogoi R., Hall A., Panhuysen M., Echevarria D., Sussel L., Weisenhorn D.M., Martinez S., Arenas E., Simeone A., Wurst W. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 2006, 133:89-98.
33. Kirkeby A., Grealish S., Wolf D.A., Nelander J., Wood J., Lundblad M., Lindvall O., Parmar M. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012, 1:703-714.
34. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., Yang L., Beal M.F., Surmeier D.J., Kordower J.H., Tabar V., Studer L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
35. Chung S., Leung A., Han B.S., Chang M.Y., Moon J.I., Kim C.H., Hong S., Pruszak J., Isacson O., Kim K.S. Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 2009, 5:646-658.
36. Chung S., Moon J.I., Leung A., Aldrich D., Lukianov S., Kitayama Y., Park S., Li Y., Bolshakov V.Y., Lamonerie T., Kim K.S. ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9703-9708.
37. Xi J., Liu Y., Liu H., Chen H., Emborg M.E., Zhang S.C. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012, 30:1655-1663.
38. Jonsson M.E., Ono Y., Bjorklund A., Thompson L.H. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp. Neurol. 2009, 219:341-354.
39. Grace A.A., Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. Off. J. Soc. Neurosci. 1989, 9:3463-3481.
40. Sommer C.A., Stadtfeld M., Murphy G.J., Hochedlinger K., Kotton D.N., Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009, 27:543-549.
41. Trzaska K.A., Kuzhikandathil E.V., Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007, 25:2797-2808.
42. Jung S., Yang H., Kim B.S., Chu K., Lee S.K., Jeon D. The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy. Neurosci. Lett. 2012, 529:133-138.
43. 2+ channel beta3 subunit leads to enhanced N-methyl-d-aspartate receptor-dependent long term potentiation and improved long term memory. J. Biol. Chem. 2008, 283:12093-12101.